INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for scleroderma lung disease: major trial underway
Disease control Recruiting nowThis study tests several new medicines to see if they can improve lung function in people with scleroderma-related lung scarring. About 400 adults will receive either an experimental drug or a placebo for one year. The main goal is to measure changes in breathing capacity.
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE
Phase: PHASE2 • Sponsor: Scleroderma Research Foundation, Inc. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Scientists hunt for clues to stop rare, deadly scleroderma
Knowledge-focused Recruiting nowThis study aims to understand what causes systemic sclerosis (SSc), a rare and serious disease that causes hardening of the skin and lungs. Researchers will collect blood, skin, and DNA samples from 150 people with SSc in Sweden to find markers that predict disease activity and t…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE
Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 05:36 UTC